Evidence map›Paper›PMID 31829180›Full record

ArticleBMC complementary and alternative medicine2019

Anti-adipogenic and anti-obesity activities of purpurin in 3T3-L1 preadipocyte cells and in mice fed a high-fat diet.

Woo Nam, Seok Hyun Nam, Sung Phil Kim, Carol Levin, Mendel Friedman

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Targeted3 Biotech · 2025
    Article
  3. International journal of molecular sciences · 2025
    Article
  4. Emerging Role ofMini reviews in medicinal chemistry · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Pharmacological blockage of the AHR-CYP1A1 axis: a call for in vivo evidence.Journal of molecular medicine (Berlin, Germany) · 2022
    Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Remedying the Mitochondria to Cure Human Diseases by Natural Products.Oxidative medicine and cellular longevity · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Woo NamDepartment of Biological Science, Ajou University, Suwon, 16499, Republic of Korea.
Seok Hyun NamDepartment of Biological Science, Ajou University, Suwon, 16499, Republic of Korea.
Sung Phil KimResearch Institute of Basic Science, Ajou University, Suwon, 16499, Republic of Korea. ksp1108@ajou.ac.kr.
Carol LevinWestern Regional Research Center, Agricultural Research Service, U.S. Department of Agriculture, Albany, California, 94710, USA.
Mendel FriedmanWestern Regional Research Center, Agricultural Research Service, U.S. Department of Agriculture, Albany, California, 94710, USA. mendel.friedman@ars.usda.gov.ORCID http://orcid.org/0000-0003-2582-7517
Ajou University · KRWestern Regional Research Center · USSTR Biotech (South Korea) · KR

Funding

Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries 314076-3Ministry of SMEs and Startups S2389154
6 · The paper itself

Abstract

backgroundThe body responds to overnutrition by converting stem cells to adipocytes. In vitro and in vivo studies have shown polyphenols and other natural compounds to be anti-adipogenic, presumably due in part to their antioxidant properties. Purpurin is a highly antioxidative anthraquinone and previous studies on anthraquinones have reported numerous biological activities in cells and animals. Anthraquinones have also been used to stimulate osteoblast differentiation, an inversely-related process to that of adipocyte differentiation. We propose that due to its high antioxidative properties, purpurin administration might attenuate adipogenesis in cells and in mice.

methodsOur study will test the effect purpurin has on adipogenesis using both in vitro and in vivo models. The in vitro model consists of tracking with various biomarkers, the differentiation of pre-adipocyte to adipocytes in cell culture. The compound will then be tested in mice fed a high-fat diet. Murine 3T3-L1 preadipocyte cells were stimulated to differentiate in the presence or absence of purpurin. The following cellular parameters were measured: intracellular reactive oxygen species (ROS), membrane potential of the mitochondria, ATP production, activation of AMPK (adenosine 5'-monophosphate-activated protein kinase), insulin-induced lipid accumulation, triglyceride accumulation, and expression of PPARγ (peroxisome proliferator activated receptor-γ) and C/EBPα (CCAAT enhancer binding protein α). In vivo, mice were fed high fat diets supplemented with various levels of purpurin. Data collected from the animals included anthropometric data, glucose tolerance test results, and postmortem plasma glucose, lipid levels, and organ examinations.

resultsThe administration of purpurin at 50 and 100 μM in 3T3-L1 cells, and at 40 and 80 mg/kg in mice proved to be a sensitive range: the lower concentrations affected several measured parameters, whereas at the higher doses purpurin consistently mitigated biomarkers associated with adipogenesis, and weight gain in mice. Purpurin appears to be an effective antiadipogenic compound.

conclusionThe anthraquinone purpurin has potent in vitro anti-adipogenic effects in cells and in vivo anti-obesity effects in mice consuming a high-fat diet. Differentiation of 3T3-L1 cells was dose-dependently inhibited by purpurin, apparently by AMPK activation. Mice on a high-fat diet experienced a dose-dependent reduction in induced weight gain of up to 55%.

Indexed as

Diet, High-Fat3T3-L1 CellsAdipogenesisAdipose TissueAnimalsAnthraquinonesAnti-Obesity AgentsAntioxidantsBody WeightMaleMiceMice, Inbred C57BLObesityAnthraquinonesAnti-Obesity AgentsAntioxidantspurpurin anthraquinoneAdipogenesisAnthraquinoneAntioxidantCell differentiationLipogenic dietMadderMitochondriaObesityRubia cordifolia

Identifiers

PMID31829180
PMCPMC6907186
OpenAlexW2995731864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.